| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2035053 | Cell | 2016 | 4 Pages |
Abstract
Knowledge of the parameters of drug development can greatly aid academic scientists hoping to partner with pharmaceutical companies. Here, we discuss the three major pillars of drug development—pharmacodynamics, pharmacokinetics, and toxicity studies—which, in addition to pre-clinical efficacy, are critical for partnering with Big Pharma to produce novel therapeutics.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry, Genetics and Molecular Biology (General)
Authors
Stuart A. Lipton, Christer Nordstedt,